Funding
← Back to your selection

Andera Partners

Activity from announced rounds

All recorded activity
Rounds participated in
4
Confirmed lead rounds
1
2 roles undisclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
$218.5M
3 disclosed · full round size, not this investor’s share

By stage

Series A1
Series B1
Series C+1
Undisclosed1

By primary sector

Biotech2
Healthtech2

By country

France1
Germany1
Switzerland1
United States1

Rounds

4 in all activity
Nouscom

Clinical-stage biotech developing neoantigen-based cancer immunotherapies.

€120MSeries D
Participant
HighLife

HighLife Medical develops a transcatheter mitral-valve replacement system designed to treat patients with severe mitral regurgitation without open-heart surgery.

€80MFinancing round
Lead
Exciva

Develops novel therapies for behavioral symptoms associated with Alzheimer's Disease

€51MSeries B
Role not disclosed
Spiro Medical

Develops a Pulmonary Neuromodulation System for asthma treatment

$67MSeries A
Role not disclosed